Fig. S1. Expression of CDC45L protein in lung cancer tissues.

Fig. S2. Expression of CDC45L protein in normal tissues.

Fig. S3. Induction of CDC45L-specific human CTL from CD8+ T cells of HLA-A24-positive lung cancer patients.

Fig. S4. CDC45L-specific cytotoxic activity of human CTL generated from two healthy donors by stimulation with the mixture of three CDC45L-derived peptides.

Table S1. Candidate peptides derived from human CDC45L predicted to be bound to HLA-A24 (A*24:02)

Data S1. Materials and methods.

CAS_1865_sm_FigureS1.pdf339KSupporting info item
CAS_1865_sm_FigureS2.pdf339KSupporting info item
CAS_1865_sm_FigureS3.pdf80KSupporting info item
CAS_1865_sm_FigureS4.pdf50KSupporting info item
CAS_1865_sm_Suppmaterialsandmethods.doc32KSupporting info item
CAS_1865_sm_TableS1.doc61KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.